Biomarin Pharmaceutical (BMRN) Operating Income (2009 - 2026)
Biomarin Pharmaceutical (BMRN) reported Operating Income of $110.92 million for Q2 2026, down 59.9% from $276.89 million a year earlier and down 14.4% from the prior quarter.
Powered by 
Analysis
Biomarin Pharmaceutical (BMRN) Operating Income (2009 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Biomarin Pharmaceutical's Operating Income came in at $149.26 million, down 80.8% year-over-year; for FY2025, it was $409.48 million, down 15.4% from FY2024.
- By year, Operating Income came in at $484.21 million in FY2024 (+160.6%), $185.77 million in FY2023 (+15.4%), $160.97 million in FY2022 and -$82.34 million in FY2021.
- Five-year quarterly Operating Income spans a low of -$65.88 million in Q4 2021 and a high of $276.89 million in Q2 2025.
- Year over year, Operating Income gained in four of the last six quarters, with growth averaging 157.6%.
- The high point for year-over-year Operating Income in five years was Q4 2024 (growth of 491.7%); the low point was Q2 2026 (a decline of 59.9%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $129.64 million (Q1 2026), -$44.61 million (Q4 2025) and -$46.69 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 11.75 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 7.14 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 6.43 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | -584.00 Mn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 4.75 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 3.16 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 3.51 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | -10.39 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 4.27 Bn |
| 10 | Biomarin Pharmaceutical | 11.31 Bn | 5.18 Bn | 786.91 Mn | 110.92 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 110.92 Mn |
| Mar 31, 2026 | 129.64 Mn |
| Dec 31, 2025 | -44.61 Mn |
| Sep 30, 2025 | -46.69 Mn |
| Jun 30, 2025 | 276.89 Mn |
| Mar 31, 2025 | 223.89 Mn |
| Dec 31, 2024 | 161.41 Mn |
| Sep 30, 2024 | 113.89 Mn |
| Jun 30, 2024 | 120.45 Mn |
| Mar 31, 2024 | 88.46 Mn |
| Dec 31, 2023 | 27.28 Mn |
| Sep 30, 2023 | 30.53 Mn |
| Jun 30, 2023 | 65.57 Mn |
| Mar 31, 2023 | 62.40 Mn |
| Dec 31, 2022 | -13.09 Mn |
| Sep 30, 2022 | -2.42 Mn |
| Jun 30, 2022 | 39.15 Mn |
| Mar 31, 2022 | 137.33 Mn |
| Dec 31, 2021 | -65.88 Mn |
| Sep 30, 2021 | -53.22 Mn |
API Access
Biomarin Pharmaceutical Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-income&ticker=BMRN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-income", "ticker": "BMRN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-income&ticker=BMRN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();